Yohimbine treatment reverses type 2
20th October 2014
Researchers have used a restricted a2A-adrenergic receptor antagonist to reverse type 2 diabetes in people whose condition is linked to a common genetic variant.

To ensure you get the right membership, please select your vocation:
Please select your industry or profession